Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug safety
Pharma
FDA raises safety flags ahead of adcomm for AZ's Andexxa
As outside experts prepare to discuss AstraZeneca’s Andexxa, the FDA has flagged “major safety findings” linked to the bleeding reversal agent.
Fraiser Kansteiner
Nov 20, 2024 8:33am
Citing labeling glitch, Endo expands clonazepam recall
Nov 19, 2024 1:52pm
FDA revisits CAR-T boxed warning on secondary cancers: Marks
Nov 1, 2024 10:30am
In 3rd bankruptcy bid, J&J sweetens talc settlement offer to $8B
Sep 23, 2024 9:33am
ESMO: GSK's Zejula, pharma&'s Rubraca-Opdivo combo disappoint
Sep 14, 2024 8:45am
Eisai, Biogen's Leqembi nabs UK nod but not reimbursement
Aug 22, 2024 9:23am
